Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 157.72M | 165.95M | 222.81M | 199.86M | 178.94M | 199.28M |
Gross Profit | 46.13M | 48.94M | 57.44M | 62.26M | 58.91M | 78.06M |
EBITDA | 4.43M | 7.00M | 15.79M | 20.76M | 20.37M | 29.41M |
Net Income | -2.90M | -798.00K | 5.51M | 10.85M | 12.44M | 19.38M |
Balance Sheet | ||||||
Total Assets | 260.20M | 253.20M | 257.50M | 258.22M | 220.95M | 185.46M |
Cash, Cash Equivalents and Short-Term Investments | 44.20M | 35.19M | 29.44M | 46.98M | 57.78M | 39.92M |
Total Debt | 25.23M | 25.64M | 27.78M | 28.63M | 4.19M | 1.65M |
Total Liabilities | 75.85M | 66.43M | 69.94M | 76.17M | 49.75M | 61.95M |
Stockholders Equity | 184.35M | 186.76M | 187.56M | 182.05M | 171.20M | 123.50M |
Cash Flow | ||||||
Free Cash Flow | 7.89M | 10.45M | -13.84M | -35.26M | -19.37M | 12.82M |
Operating Cash Flow | 8.49M | 10.51M | -6.48M | 14.37M | -17.05M | 13.17M |
Investing Cash Flow | 284.00K | 189.00K | -5.46M | -47.52M | -1.40M | -90.00K |
Financing Cash Flow | -5.82M | -4.95M | -5.60M | 22.35M | 36.31M | -4.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | €63.61B | 5.58 | 5.56% | 4.79% | -19.10% | -30.15% | |
79 Outperform | $62.75B | 6.39 | 14.62% | 4.80% | 1.21% | 2.15% | |
70 Outperform | $20.69B | 7.64 | 5.64% | 5.33% | 5.93% | -3.64% | |
65 Neutral | $10.77B | 15.80 | 5.51% | 1.90% | 3.03% | -26.66% | |
52 Neutral | HK$33.00M | ― | -7.37% | ― | -23.17% | -200.00% | |
45 Neutral | HK$315.58M | ― | ― | -34.67% | -99.72% | ||
40 Underperform | HK$792.00M | ― | -2.26% | ― | 34.69% | 41.09% |